The deal with startup Dren Bio hands Sanofi a so-called myeloid cell engager that would compete with an array of programs ...

Orphan Drug Designation follows positive Phase 1 data presented at the 12th International Workshop on Waldenström ...

Bexobrutideg, a bioavailable agent, was granted orphan drug designation by the FDA for Waldenström macroglobulinemia, a type ...

You can increase white blood cells (WBCs) by taking certain medications and eating immune-boosting foods, like yogurt, lean protein foods, antioxidant-rich vegetables, and more. Maintaining a normal ...

We compared obinutuzumab, a humanised type II anti-CD20 monoclonal antibody that induces potent B-cell depletion, with placebo for the treatment of LN in combination with standard therapies. Methods ...

10 - Shoreline Biosciences: The cell therapy biotech plans to let go of an undisclosed number of employees tied to a project with Gilead Sciences’ Kite Pharma. Story Jan. 9 - IGM Biosciences ...

Using an unbiased approach, this important study discovered a role of Ezh2 in the differentiation of granule neuron precursors, the cell of origin for Shh group of medulloblastoma. Furthermore, the ...

Detection of HAV RNA before IgM anti-HAV seroconversion may be used ... Hematopoietic stem cell transplant recipients lose immune memory of exposure to infectious agents and vaccines accumulated ...

The indirect allorecognition pathway is required for B-cell activation and alloantibody production and it is presumably the driving force behind chronic allograft rejection. There is accumulating ...